BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2907350)

  • 1. Hypotensive and regional haemodynamic effects of fenoldopam and quinpirole in the anaesthetized rat.
    Van der Niepen P; Dupont AG; Finne E; Six RO
    J Hypertens Suppl; 1988 Dec; 6(4):S687-9. PubMed ID: 2907350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the hypotensive action of dopamine receptor agonists fenoldopam and quinpirole in anaesthetized rats.
    Sengupta S; Lokhandwala MF
    J Auton Pharmacol; 1985 Dec; 5(4):289-94. PubMed ID: 2869041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective antagonism of the hypotensive effects of dopamine agonists in spontaneously hypertensive rats.
    McCoy CE; Douglas FL; Goldberg LI
    Hypertension; 1986 Apr; 8(4):298-302. PubMed ID: 2870024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular characterization of DA-1 and DA-2 dopamine receptor agonists in anesthetized rats.
    Cavero I; Thiry C; Pratz J; Lawson K
    Clin Exp Hypertens A; 1987; 9(5-6):931-52. PubMed ID: 2887315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.
    Dupont AG; Lefebvre RA; Vanderniepen P
    Br J Pharmacol; 1987 Jul; 91(3):493-501. PubMed ID: 2886174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists.
    Pellissier G; Demenge P
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):548-55. PubMed ID: 1724532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotensive and regional hemodynamic effects of the dopamine receptor agonist SK & F 85174 in the anesthetized rat.
    Van der Niepen P; Schoors DF; Dupont AG
    Arch Int Pharmacodyn Ther; 1991; 313():98-107. PubMed ID: 1687774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular characterization of the DA2 dopamine receptor agonist quinpirole in rats.
    Lefevre-Borg F; Lorrain J; Lechaire J; Thiry C; Lhoste F; Hicks PE; Cavero I
    Fundam Clin Pharmacol; 1987; 1(3):179-200. PubMed ID: 2892767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of dopamine receptor subtypes in the hypotensive action of SK&F 85174 in anesthetized rats.
    Sowinski BA; Lokhandwala MF
    J Auton Pharmacol; 1987 Jun; 7(2):105-9. PubMed ID: 2888767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of cyclic-AMP in the hypotensive response to fenoldopam but not to quinpirole in the anaesthetized rat.
    Hegde SS; Lokhandwala MF
    J Auton Pharmacol; 1988 Mar; 8(1):63-8. PubMed ID: 2455721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective antagonism of renal hemodynamic changes induced by dopamine, DPDA, fenoldopam and quinpirole in the rat.
    Rosenkranz RP; McClelland DL
    Proc West Pharmacol Soc; 1987; 30():25-36. PubMed ID: 2888129
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of fenoldopam on regional vascular resistance in conscious spontaneously hypertensive rats.
    Lappe RW; Todt JA; Wendt RL
    J Pharmacol Exp Ther; 1986 Jan; 236(1):187-91. PubMed ID: 2867214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanisms of the development of tolerance to the hypotensive effects of fenoldopam in rats.
    Lefèvre-Borg F; Lorrain J; Lechaire J; Thiry C; Hicks PE; Cavero I
    J Cardiovasc Pharmacol; 1988 Apr; 11(4):444-55. PubMed ID: 2453748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of dopamine receptors in the stellate ganglia with selective DA1 and DA2 receptor agonists and antagonists.
    Sabouni MH; Alkadhi KA; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Jan; 236(1):65-70. PubMed ID: 2867216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and pharmacological characterization of ganglionic dopamine receptors.
    Sabouni MH; Alkadhi KA; Lokhandwala MF
    Clin Exp Hypertens A; 1987; 9(5-6):873-87. PubMed ID: 2887312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of quinpirole on neurogenic vasoconstriction in the in situ autoperfused hindquarters and renal vascular beds of the rat.
    Roquebert J; Moran A; Demichel P
    J Auton Pharmacol; 1992 Oct; 12(5):291-8. PubMed ID: 1358890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effects of SKF 82526 and LY 171555 on presynaptic (DA2) and postsynaptic (DA1) dopamine receptors in rat kidney.
    Lokhandwala MF; Steenberg ML
    J Auton Pharmacol; 1984 Dec; 4(4):273-7. PubMed ID: 6152269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the dopamine receptor agonists, fenoldopam and quinpirole, in the rat stomach.
    Lefebvre RA; Guenaneche F; De Beurme FA
    Eur J Pharmacol; 1990 Aug; 185(1):69-79. PubMed ID: 1977599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurogenic vasodilatation produced by fenoldopam in the rat hindquarters vascular bed.
    Van der Niepen P; Lefebvre RA; Dupont AG
    J Auton Pharmacol; 1987 Dec; 7(4):331-8. PubMed ID: 2895108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.